September 11, 2025

Early TAVR Delays Declines in Left Ventricular/Left Atrial Function for Patients With Severe Aortic Stenosis

Early TAVR preserved heart health in asymptomatic severe aortic stenosis, reinforcing benefits of earlier intervention.

Conexiant

September 05, 2025

AI Tops Guidelines in Classifying Aortic Stenosis

Gradient-boosted model shows higher diagnostic accuracy—especially for severe AS—in low-flow cases where guideline-based metrics often yield discordant results.

Conexiant

August 18, 2025

Join Us at the Seventh Mount Sinai International Prostate Cancer Symposium & World Congress of Urologic Oncology

Date: December 3-5, 2025 Location: The Mount Sinai Hospital, New York City

Mount Sinai New York

June 02, 2025

Exercise After Chemotherapy Improves Colorectal Cancer Survival

A long-term clinical trial found that structured exercise after colon cancer treatment improved survival outcomes and reduced recurrence rates, offering evidence to support physical activity as part of survivorship care.

Conexiant

May 31, 2024

The Future Is Now: Advancements in IBD Management and Interventional Endoscopy Techniques

Join us on November 2, 2024, at Morristown Medical Center for a deep dive into IBD management and interventional endoscopy advancements, featuring notable experts and CME opportunities.

Atlantic Health System

May 07, 2025

Pancreatitis Prevention: Just a Myth?

A major study finds no benefit from a common surgery long used to prevent pancreatitis.

Reuters

May 05, 2025

Missed Screenings? Anal Cancer Surge in Women

Rates rising 4.3% in white women over 65, outpacing increases in other demographics.

Conexiant

July 01, 2025

Stem Cell Therapy Shows T1D Reversal Potential

A new stem cell–derived islet therapy showed insulin independence, restored beta-cell function, and prevented severe hypoglycemia in type 1 diabetes, based on interim results presented at the ADA’s 85th Scientific Sessions.

Conexiant

May 06, 2025

Shorter Prostate Radiotherapy Proves Long-Term Match

Two-week radiation treatment for localized prostate cancer delivers equivalent 10-year outcomes to standard 8-week course in a clinical trial.

Conexiant